Elanco Animal Health EBITDA 2016-2024 | ELAN

Elanco Animal Health EBITDA for the quarter ending December 31, 2024 was $0.165B, a 13.79% increase year-over-year.

  • Elanco Animal Health 2024 EBITDA was 0.763B, a 612.08% decline from 2023.
  • Elanco Animal Health 2023 EBITDA was -0.149B, a 116.87% decline from 2022.
  • Elanco Animal Health 2022 EBITDA was 0.883B, a 128.76% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Elanco Animal Health EBITDA 2016-2024 | ELAN

  • Elanco Animal Health 2024 EBITDA was 0.763B, a 612.08% decline from 2023.
  • Elanco Animal Health 2023 EBITDA was -0.149B, a 116.87% decline from 2022.
  • Elanco Animal Health 2022 EBITDA was 0.883B, a 128.76% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$21.5B
Quest Diagnostics (DGX)$19.2B
DaVita (DVA)$12.4B
Encompass Health (EHC)$10.2B
Chemed (CHE)$8.4B
Option Care Health (OPCH)$5.5B
RadNet (RDNT)$4.8B
LifeStance Health (LFST)$3.1B
Amedisys (AMED)$3B
Astrana Health (ASTH)$2.2B
Addus HomeCare (ADUS)$2.1B
U.S Physical Therapy (USPH)$1.3B
Aveanna Healthcare Holdings (AVAH)$968M
Pennant (PNTG)$927M
Atai Life Sciences (ATAI)$351M
Bioqual (BIOQ)$54M
Daxor (DXR)$35M
Ontrak (OTRK)$7M
MEDIROM Healthcare Technologies (MRM)$4M
IMAC Holdings (BACK)$1M
Psychemedics (PMD)$0M